- Home
- Applications
- clinical metadata governance and trial
Refine by
Clinical Metadata Governance And Trial Product Applications For The Served Medical Health Care Industry
36 applications found
Prancer RTSM provides the flexibility you need to explore all the possible paths for determining the optimal dose, patient population, and combination therapies within your Phase 2 ...
By4G Clinical based in Wellesley, MASSACHUSETTS (USA)
This trial uses our unmodified GDT cells derived from healthy donors, in a dose escalation study to establish safety of the allogeneic platform. This trial is open. ...
ByTC BioPharm based in Holytown, UNITED KINGDOM
With 3BP’s theragnostic approach, you can see where your drug is going and monitor the efficacy of the treatment. This allows the identification of likely responders leading to faster and cost-efficient clinical trials and increased chances of successful treatment. It also allows personalized dosing based on individual imaging data, thus achieving maximal therapeutic effect with minimal unwanted side effects. ...
By3B Pharmaceuticals GmbH based in Berlin, GERMANY
This trial investigated the safety profile of large numbers of GDT cells derived from patients and was open to certain patients with skin, kidney or lung cancers. This trial is now closed. ...
ByTC BioPharm based in Holytown, UNITED KINGDOM
The first product candidate to utilize the Discogenic Cell platform is IDCT ...
ByDiscGenics, Inc. based in Salt Lake City, UTAH (USA)
Health care is a competitive industry where technology can build strong processes to transform and reform health care operations For health care providers, they need to harvest the benefits of technology which will increase the chances of positive outcomes from the market There is a need for health care organizations to modernize their management services to survive in the competitive ...
ByEminenture Pvt Ltd based in Bundall, AUSTRALIA
People who have suffered a Traumatic Brain Injury have successfully used a REX. A clinical trial has been conducted by the Australian Institute of Neuro-rehabilitation (AIN), Nelson Bay, New South Wales (NSW), Australia and the University of Newcastle, NSW; and is supported by The Newcastle Permanent Charitable Foundation and Rex Bionics plc. The trial was open to volunteers from the Hunter Region of NSW, who have had a Stroke or Traumatic Brain Injury more than three months previously and have difficulty ...
ByRex Bionics Ltd based in Auckland, NEW ZEALAND
Challenge: Aging is most visible in the face, yet it is the most difficult area of skin assessment. We enable: Personalized skin assessment and individual monitoring of aging in the ...
ByCitus AG based in Dübendorf, SWITZERLAND
Now is the time to treat a larger population in your pivotal trials to support global submissions and market expansion. Prancer RTSM? helps you navigate the complexity of global supply chains as well as provides the complete data story needed for successful regulatory ...
By4G Clinical based in Wellesley, MASSACHUSETTS (USA)
REX is used by physiotherapists for people with mobility impairments, in rehabilitation centres in the US, the UK, the Middle East, Australia and New Zealand. ...
ByRex Bionics Ltd based in Auckland, NEW ZEALAND
The development of highly cytotoxic drugs is needed for the success of the treatment in tumor cells. Paradoxically, the high toxicity limits its efficacy and application in vivo, causing damage to non-target organs and severe secondary effects. The use of directed liposomes has allowed the advance of many cancer drugs to preclinical and clinical trials, reducing side effects, and increasing their therapeutic index at the same time. More than 15 cancer liposomed drugs are currently clinically ...
ByNanovex Biotechnologies based in Llanera, SPAIN
PLGA nanospheres have already been successfully used in vitro and in clinical trials. Results show that drugs encapsulated in PLGA nanoparticles have superior accumulation in the tumor environment, reduced tumor size and enhanced inhibition of cell proliferation. This is thanks to increased cell penetration and reduced toxicity of encapsulated compounds. Because of the higher accumulation in tumoral areas PLGA nanoparticles are also useful for cancer diagnosis and imaging which has a key role in clinical oncology ...
ByNanovex Biotechnologies based in Llanera, SPAIN
Data from examining the immune repertoire of cancer patients can be used to identify patterns associated with positive outcomes and monitor the progress of immunotherapies in clinical trials. Single cell immune sequencing technologies provide an even more granular view of individual T cell or B cell populations following immunotherapy, providing unprecedented detail for informing cancer ...
ByiRepertoire, Inc. based in Huntsville, ALABAMA (USA)
Data from examining the immune repertoire of cancer patients can be used to identify patterns associated with positive outcomes and monitor the progress of immunotherapies in clinical trials. Single cell immune sequencing technologies provide an even more granular view of individual T cell or B cell populations following immunotherapy, providing unprecedented detail for informing cancer ...
ByiRepertoire, Inc. based in Huntsville, ALABAMA (USA)
Zymeworks’ mission is to develop transformative treatments that help patients return home to their loved ones, disease-free. In order to bring new treatments to patients, we conduct clinical trials to assess the safety and efficacy of our investigational medicines. This information is submitted to regulatory agencies, such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency, and Health Canada, to enable approval for patient use. Most patients access Zymeworks investigational ...
ByZymeworks Inc based in Vancouver, BRITISH COLUMBIA (CANADA)
Nuubo considers that cutting edge technology can only be considered as such if it also works in real life, with real patients living a normal life. That is why Nuubo is strongly focused on clinical research. Apart from the completed and published studies, Nuubo currently has approximately 3500 patients enrolled in ongoing clinical trials, validating the Nuubo technology for real clinical use. Nuubo is conducting studies in the following ...
ByNuubo based in Edificio Spaces, SPAIN
By using our platform, we provide great opportunities for integrating metagenomic analysis into translational parts of pharmaceutical development. Our experience in metagenomic evaluation of large patient cohorts provides know-how and understanding regarding microbiome related conditions and can be applied for target evaluation, and for biomarker identification and development of subsequent patient stratification tools. The MetaboGen network contains clinicians specialized in various diseases, providing access to ...
ByMetabogen AB based in Stockholm, SWEDEN
Data Ownership and Governance as Leverage for Patient Groups to Accelerate Therapies for their Disease, Jeeva's patent pending eClinical cloud solution for rapid remote touch-less patient enrollment, electronic informed consent, and data collection to setup registries or natural history studies with bi-directional communication and frictionless user experience for coordinators and patients. ...
ByJeeva Informatics Solutions Inc. based in Manassas, VIRGINIA (USA)
As the COVID-19 pandemic continues, the SARS-CoV-2 virus is likely to become endemic with emerging novel variants, some of them seasonal. Updates to the various vaccines will be required, as will a range of anti-virals with a variety of mechanisms of action, for use in early infection and in hospitalizated patients, much like oseltamivir (Tamiflu) is used in certain populations for seasonal ...
ByCyrus Biotechnology Inc. based in Seattle, WASHINGTON (USA)
Heart failure is a progressive syndrome that begins with a chronic condition that often leads to Acute Decompensated Heart Failure, an unstable condition requiring immediate medical ...
ByViCardia Therapeutics, Inc. based in San Francisco, CALIFORNIA (USA)